Back to ITN Home

Overview and Mission
News and Press
Research Supported
Allergy / Asthma
Autoimmune Diseases
Islet Transplantation
Solid Organ Transplantation
Tolerance Assay Studies
Core Facilities
All Clinical Trials
All ITN Publications


Clinical Trials Seeking Patients

Contact Information

Islet Transplantation Research
| Public Access Site for Researchers |


Boutique Real Time PCR Core

Locations: Harvard University, Boston, MA
New York Presbyterian Hospital (Cornell), New York, NY

Overview | Investigators | Background

Overview

Real-time PCR Cores, located at Harvard University (Director, Terry Strom, M.D.) and Cornell University (Director, M. Suthantiran, M.D.) are supported by the ITN to perform real-time PCR analyses on peripheral blood, urine and tissue for several genes implicated in acute rejection, tolerance or tolerance breakdown.

These genes include, but are not limited to granzyme B, cyclooxygenase, perforin, IL-10, IL-7 and IL-15. Quantitative PCR is performed to assess relative expression levels of these genes between normal controls and patients, and in single patients at various timepoints. These intent is to to track such parameters as disease onset, disease progression and patient responses to therapeutics.

Top of PageParticipating Investigators

Terry Strom, Beth Israel Deaconess Medical Center, Harvard University
Manikkam Suthanthiran, Cornell University Medical Center

Top of PageBackground Articles

Quantification of mRNA using real-time RT-PCR: trends and problems
- J Mol Endocrinol [go]
Real-time multiplex PCR assays - Methods [go]
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression - Methods [go]

 


HomeTerms | © 2002-5 Immune Tolerance Network | Sponsors: NIAID, NIDDK and JDRF | Search